Fourth AHA Journal to Debut in August

The American Heart Association has set August for the premier of Circulation: Cardiovascular Interventions, the fourth in a series of six new titles to be published under the banner of Circulation: Journal of the American Heart Association. The journals will be published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

David P. Faxon, M.D., has been named editor of the new journal. Faxon is director of strategic planning in the department of medicine at Brigham and Women's Hospital, Boston, and chief of cardiology at West Roxbury (Mass.) Veterans Administration Hospital.

The publication fulfills the need for a prestigious journal devoted to this rapidly expanding field, according to Faxon. "In the past, the most important papers in interventional cardiology appeared in general cardiology journals," he said. "Today, at a time when at least 50 percent of cardiologists practice either invasive or interventional cardiology, clinicians and academicians need an excellent journal in this area."

The new journal's major objective will be to present the highest-quality original research from all areas of interventional cardiology--including coronary artery disease, such as angioplasty and stents; structural heart disease, including valvular and congenital heart disease; and vascular disease, including peripheral, aortic, renal, and cerebral vascular disease.

"A priority will be placed on original research and on randomized trials and large registry studies that significantly advance the field," Faxon said.

The publication will also feature timely reviews of cutting-edge advances, cardiac physiology and pathophysiology relevant to clinical practice, and expert viewpoints on current controversies in interventional cardiology. Letters to the editors and imaging and case studies will provide a unique forum for the global interventional cardiology community.

Faxon encourages potential authors to submit their work for consideration. "We're actively seeking top-quality research and other articles that further the practice and clinical outcomes of interventional cardiology," he said.

For more information, go to http://circ.ahajournals.org/misc/ifora_interventions.shtml.

Product Showcase

  • SlateSafety BAND V2

    SlateSafety BAND V2

    SlateSafety's BAND V2 is the most rugged, easy-to-use connected safety wearable to help keep your workforce safe and help prevent heat stress. Worn on the upper arm, this smart PPE device works in tandem with the SlateSafety V2 system and the optional BEACON V2 environmental monitor. It includes comprehensive, enterprise-grade software that provides configurable alert thresholds, real-time alerts, data, and insights into your safety program's performance all while ensuring your data is secure and protected. Try it free for 30 days. 3

Featured

Webinars